Relief Therapeutics Holding SA announced the appointments, effective May 23, 2022, of Tracy Truong and Kelli Powell, as Regional Clinical Specialists for the West and Northeast Regions, respectively. Both Ms. Truong and Ms. Powell will report directly to Chris Wick, Executive Director and Head of U.S. Sales. Ms. Truong will join Relief from Alexion where, since 2017, she served as a Regional Account Manager promoting Strensiq, an enzyme replacement therapy indicated for hypophosphatasia, an ultra-rare genetic disorder.

Prior to that, she was a Regional Account Manager at Shire/NPS Pharma representing Gattex, indicated for the rare, ultra-orphan disease, short bowel syndrome. Ms. Powell will join Relief from Alexion where, since 2014, she served as a Regional Account Manager, and Interim Regional Sales Director and Trainer, developing strategic relationships with physicians to identify patients with two ultra-rare diseases.